OraSure Technologies, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving OraSure Technologies, Inc. now
Current reporting with the operating signal separated from the noise.
OraSure Technologies, Inc.: OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
The story matters when it changes OraSure Technologies, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient-Friendly Access to Testing for Sexually Transmitted Infections
The story matters when it changes OraSure Technologies, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2025 Earnings Call Transcript
Investors are testing whether OraSure Technologies, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript
Investors are testing whether OraSure Technologies, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025
The story matters when it changes OraSure Technologies, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.OraSure Technologies, Inc. Expands Diagnostic Portfolio with Acquisition of Sherlock Biosciences, Inc.
The story matters when it changes OraSure Technologies, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.OraSure Technologies, Inc. (NASDAQ:OSUR): Interview with CEO and President Carrie Eglinton Manner
The story matters when it changes OraSure Technologies, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
The story matters when it changes OraSure Technologies, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Orasure Technologies, Inc. Q1 2008 Earnings Call Transcript
Investors are testing whether OraSure Technologies, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest OSUR filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
OraSure Technologies, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
SEARCH Q2 COVERAGE →Third quarter
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →